Loading...
Loading...
All product recalls associated with Cryolife Inc.
Total Recalls
68
Past Year
0
Class I (Serious)
0
Most Recent
Oct 2021
Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.
The Amphotericin B Intermediate (G10030), one of the components of the antimicrobial solution, had reached expiration at the time it was utilized to manufacture the Combo Antibiotic Stock Solution (G10070).
The Amphotericin B Intermediate (G10030), one of the components of the antimicrobial solution, had reached expiration at the time it was utilized to manufacture the Combo Antibiotic Stock Solution (G10070).
The Amphotericin B Intermediate (G10030), one of the components of the antimicrobial solution, had reached expiration at the time it was utilized to manufacture the Combo Antibiotic Stock Solution (G10070).
CryoLife conducted a retrospective review which revealed the sterilization cycle of instruments used during processing of various tissues could not be confirmed as acceptable.
During a retrospective review, CryoLife identified positive microbiological culture results for donor tissues associated with various allografts.
CryoLife conducted a retrospective review which revealed the sterilization cycle of instruments used during processing of various tissues could not be confirmed as acceptable.
CryoLife conducted a retrospective review which revealed the sterilization cycle of instruments used during processing of various tissues could not be confirmed as acceptable.
CryoLife conducted a retrospective review which revealed the sterilization cycle of instruments used during processing of various tissues could not be confirmed as acceptable.
CryoLife conducted a retrospective review which revealed the sterilization cycle of instruments used during processing of various tissues could not be confirmed as acceptable.
CryoLife conducted a retrospective review which revealed the sterilization cycle of instruments used during processing of various tissues could not be confirmed as acceptable.
CryoLife conducted a retrospective review which revealed the sterilization cycle of instruments used during processing of various tissues could not be confirmed as acceptable.
During a retrospective review, CryoLife identified positive microbiological culture results for donor tissues associated with various allografts.
This recall was initiated as part of the firm's retrospection review of tissues associated with complaints of alleged recipient infection.
This recall was initiated as part of the firm's retrospection review of tissues associated with complaints of alleged recipient infection.
CryoLife received information regarding a positive culture for Group A Streptococcus infection in a recipient of tissue procured from the attached donor.
The donor of the tissue had a viral syndrome at the time of death.
The donor of the tissue had a viral syndrome at the time of death.
A retrospective review of donor files conducted by CryoLife revealed an expired solution had been used during processing of the associated tissues.
A retrospective review of donor files conducted by CryoLife revealed an expired solution had been used during processing of the associated tissues.
Microorganisms were detected in donor tissue associated with this allograft, specifically Aeormonas hydrophila.